{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:34:02Z","timestamp":1792506842350,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Interleukin (IL)-18 is markedly elevated in systemic inflammatory diseases that cause the \u2018cytokine storm\u2019 such as adult-onset Still\u2019s disease (AOSD) and hemophagocytic lymphohistiocytosis (HLH). The differences in IL-18 between AOSD and HLH, especially in adults, is uncertain. Macrophage activation syndrome (MAS), a form of secondary HLH, is often difficult to differentiate cases of AOSD that include MAS from other secondary HLH. In this case-control study, we investigated whether serum IL-18 levels could be a useful biomarker for the differential diagnosis of AOSD with or without MAS (AOSD group) and other secondary HLH in adults (adult HLH group).<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p>We enrolled 46 patients diagnosed with AOSD including 9 patients with MAS and 31 patients in the adult HLH group, which excluded AOSD-associated MAS. The clinical features and laboratory data were compared between the AOSD and adult HLH groups. In addition, we subdivided the AOSD group (with or without MAS) and the adult HLH group (whether lymphoma-associated or not) and compared the four groups. A logistic regression analysis was used to identify factors with high efficacy in differentiating the two groups, followed by a receiver operating characteristic (ROC) curve analysis to evaluate the differential diagnostic ability of IL-18. We analyzed the correlation between IL-18 and various laboratory parameters in the AOSD group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum IL-18 levels of patients in the AOSD groups were significantly higher than those of the adult HLH groups, and were closely correlated with ferritin, soluble interleukin-2 receptor (sIL-2R), and other laboratory data. Univariate and multivariate logistic regression analyses revealed that IL-18, sIL-2R, and \u2018arthralgia or arthritis\u2019 are independent factors useful in the differential diagnosis of AOSD from adult HLH. In the differential diagnosis of both groups, the area under the curve obtained from the ROC curve of IL-18 with a cutoff value of 18,550 pg\/mL was 0.91 (95% confidence interval 0.83\u20131.00; sensitivity 90.3%, specificity 93.5%), and the differential diagnosis ability of IL-18 was superior to that of other laboratory data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>IL-18 could be a useful biomarker for the differential diagnosis of AOSD and adult HLH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.750114","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:42:50Z","timestamp":1633898570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still\u2019s Disease With\/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults"],"prefix":"10.3389","volume":"12","author":[{"given":"Toshihiko","family":"Shiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Funauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, Biomarkers and Targets for Adult-Onset Still\u2019s Disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A Comprehensive Review on Adult Onset Still\u2019s Disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-Onset Still\u2019s Disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","article-title":"Increased Neutrophil Extracellular Traps Activate NLRP3 and Inflammatory Macrophages in Adult-Onset Still\u2019s Disease","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B5","article-title":"Preliminary Criteria for Classification of Adult Still\u2019s Disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Med (Baltimore)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s1297-319x(02)00409-8","article-title":"Ferritin Levels in Adult Still\u2019s Disease: Any Sugar","volume":"69","author":"Fautrel","year":"2002","journal-title":"Joint Bone Spine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated Serum Levels of Free Interleukin-18 in Adult-Onset Still\u2019s Disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult Onset Still\u2019s Disease (AOSD) in the Era of Biologic Therapies: Dichotomous View for Cytokine and Clinical Expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/156890","article-title":"IL-18 Serum Level in Adult Onset Still\u2019s Disease: A Marker of Disease Activity","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int J Inflamm"},{"key":"B11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/jcm10050910","article-title":"Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still\u2019s Disease","volume":"10","author":"Nam","year":"2021","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2013.824023","article-title":"Interleukin-18 as an Efficient Marker for Remission and Follow-Up in Patients With Inactive Adult-Onset Still\u2019s Disease","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-Label, Multicentre, Dose-Escalating Phase II Clinical Trial on the Safety and Efficacy of Tadekinig Alfa (IL-18BP) in Adult-Onset Still\u2019s Disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheumatic Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)61048-x","article-title":"Adult Haemophagocytic Syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the Management of Hemophagocytic Lymphohistiocytosis in Adults","volume":"133","author":"La Rosee","year":"2019","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13543","article-title":"The Role of Interleukin-18 in the Diagnosis and Monitoring of Hemophagocytic Lymphohistiocytosis\/Macrophage Activation Syndrome - a Systematic Review","volume":"203","author":"Krei","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100247","article-title":"Clinical Manifestations But Not Cytokine Profiles Differentiate Adult-Onset Still\u2019s Disease and Sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2016.1167951","article-title":"Assessment of the HScore for Reactive Haemophagocytic Syndrome in Patients With Rheumatic Diseases","volume":"46","author":"Batu","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe Imbalance of IL-18\/IL-18BP in Patients With Secondary Hemophagocytic Syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3<550::Aid-anr103>3.0.Co;2-5","article-title":"Levels of Interleukin-18 and its Binding Inhibitors in the Blood Circulation of Patients With Adult-Onset Still\u2019s Disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B23","article-title":"Proinflammatory Cytokine Profiles in Sera and Pathological Tissues of Patients With Active Untreated Adult Onset Still\u2019s Disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090662","article-title":"Cytokine Profiles of Macrophage Activation Syndrome Associated With Rheumatic Diseases","volume":"37","author":"Maruyama","year":"2010","journal-title":"J Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar4193","article-title":"Involvement of TLR7 MyD88-Dependent Signaling Pathway in the Pathogenesis of Adult-Onset Still\u2019s Disease","volume":"15","author":"Chen","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2004.03.023","article-title":"Adult Still\u2019s Disease Reflects a Th2 Rather Than a Th1 Cytokine Profile","volume":"112","author":"Saiki","year":"2004","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.21164","article-title":"Association of Intercellular Adhesion Molecule-1 With Clinical Manifestations and Interleukin-18 in Patients With Active, Untreated Adult-Onset Still\u2019s Disease","volume":"53","author":"Chen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093781","article-title":"Lymph Node IL-18 Expression in Adult-Onset Still\u2019s Disease","volume":"68","author":"Conigliaro","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120079","article-title":"Serum S100A8\/A9, But Not Follistatin-Like Protein 1 and Interleukin 18, may be a Useful Biomarker of Disease Activity in Adult-Onset Still\u2019s Disease","volume":"39","author":"Kim","year":"2012","journal-title":"J Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-Onset Still\u2019s Disease and Sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-020-02200-4","article-title":"Interleukin-18 and Fibroblast Growth Factor 2 in Combination Is a Useful Diagnostic Biomarker to Distinguish Adult-Onset Still\u2019s Disease From Sepsis","volume":"22","author":"Koga","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04946-3","article-title":"Elevated Plasma Galectin-3 Levels and Their Correlation With Disease Activity in Adult-Onset Still\u2019s Disease","volume":"39","author":"Chen","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The Hyperferritinemic Syndrome: Macrophage Activation Syndrome, Still\u2019s Disease, Septic Shock and Catastrophic Antiphospholipid Syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719544","article-title":"Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still\u2019s Disease From COVID-19","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 Diagnostically Distinguishes and Pathogenically Promotes Human and Murine Macrophage Activation Syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for Predicting the Development of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8563-7","article-title":"Scd163 in AOSD: A Biomarker for Macrophage Activation Related to Hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol Res"},{"key":"B38","article-title":"Serum Cytokine Profiles in Patients With Adult Onset Still\u2019s Disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-2993-y","article-title":"Clinical Utility of Soluble Interleukin-2 Receptor in Hemophagocytic Syndromes: A Systematic Scoping Review","volume":"96","author":"Lin","year":"2017","journal-title":"Ann Hematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.02.005","article-title":"Macrophage Activation Syndrome: Serological Markers and Treatment With Anti-Thymocyte Globulin","volume":"132","author":"Coca","year":"2009","journal-title":"Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1925-8","article-title":"A High sIL-2R\/Ferritin Ratio is a Useful Marker for the Diagnosis of Lymphoma-Associated Hemophagocytic Syndrome","volume":"93","author":"Tsuji","year":"2014","journal-title":"Ann Hematol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012310","article-title":"Soluble Interleukin-2 Receptor is a Sensitive Diagnostic Test in Adult HLH","volume":"1","author":"Hayden","year":"2017","journal-title":"Blood Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13433","article-title":"Soluble Interleukin-2 Receptor (sIL-2r) Level Is a Limited Test for the Diagnosis of Adult Secondary Hemophagocytic Lymphohistiocytosis","volume":"105","author":"Naymagon","year":"2020","journal-title":"Eur J Haematol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-Onset Still Disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct Cytokine Profiles of Systemic-Onset Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome With Particular Emphasis on the Role of Interleukin-18 in its Pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-1952-1","article-title":"Correlation of Serum CX3CL1 Level With Disease Activity in Adult-Onset Still\u2019s Disease and Significant Involvement in Hemophagocytic Syndrome","volume":"31","author":"Kasama","year":"2012","journal-title":"Clin Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological Properties and Role in Disease Pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/art.11368","article-title":"Reactive Hemophagocytic Syndrome in Adult Systemic Disease: Report of Twenty-Six Cases and Literature Review","volume":"49","author":"Dhote","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3830-3","article-title":"Macrophage Activation Syndrome in Still\u2019s Disease: Analysis of Clinical Characteristics and Survival in Paediatric and Adult Patients","volume":"36","author":"Ruscitti","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2016.09.016","article-title":"Prognostic Factors of Macrophage Activation Syndrome, at the Time of Diagnosis, in Adult Patients Affected by Autoimmune Disease: Analysis of 41 Cases Collected in 2 Rheumatologic Centers","volume":"16","author":"Ruscitti","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.750114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:43:03Z","timestamp":1633898583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.750114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2021.750114"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.750114","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"article-number":"750114"}}